Cmg2019-13k persona revision knee post market usit was reported that the patient was prescribed dicoflenac to treat limited range of motion, flexion contracture, pain and stiffness approximately three (3) years following the patient's last left knee arthroplasty.Initial operative notes noted no intraoperative complications upon implantation of devices.
|
(b)(4).D10 - concomitant devices - persona revision cemented femoral component plus left size 9+ catalog#: 42504606611, lot#: 64825710, persona revision offset splined uncemented stem extension 3mm x 17mm x +135mm catalog#: 42560313517, lot#: 64769719, persona revision central femoral cone size small catalog#: 42545001011, lot#: 64751267, persona revision femoral posterior augment cemented 9, 9+ 10mm catalog#: 42556806610, lot#: 64739717, persona revision femoral distal augment cemented size 9, 9+ 5mm catalog#: 42556606605, lot#: 64707485, persona revision femoral distal augment cemented size 9, 9+ 5mm catalog#: 42556606605, lot#: 64707485, persona revision constrained condylar knee articular surface left 12mm catalog#: 42512800712, lot#: 64615631.The complainant has indicated that the product will not be returned to zimmer biomet for investigation, as the device remains implanted.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.Multiple mdr reports were filed for this patient; please see all reports associated with this event: 0001822565-2024-00664, 0001822565-2024-00665, 0001822565-2024-00666, 0001822565-2024-00667, 0001822565-2024-00668, 0001822565-2024-00670, 0001822565-2024-00671.H3 other text: investigation incomplete.
|